Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies

Arthritis and Rheumatism

Volumn 39, Issue 4, 1996, Pages 616-622

  Fries, James F ^a,c   Williams, Catherine A ^a   Morfeld, Dianne ^a   Singh, Gurkirpal ^a   Sibley, John ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AURANOFIN; AZATHIOPRINE; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSIS; DIAGNOSTIC APPROACH ROUTE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHYSICAL DISABILITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OFFICE VISITS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 0029872444     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390412     Document Type: Article

References (32)

1. Ward MM, Leigh JP, Fries JF: Progression of functional disability in patients with rheumatoid arthritis. Arch Intern Med 153:2229-2237, 1993
2. Fries JF, Williams CA, Morfeld D, Singh G, Wolfe F, Sibley J: Reduction in longterm disability in rheumatoid arthritis by DMARD-based treatment strategies (abstract). Arthritis Rheum 37 (suppl 9):S420, 1994
3. Hakala M, Nieminen P, Koivisto O: More evidence from a community based series of better outcome in rheumatoid arthritis: data on the effect of multidisciplinary care on the retention of functional ability. J Rheumatol 21:1432-1437, 1994
4. Suarez-Almazor ME, Soskolne CL, Saunders LD, Russell AS: Outcome in RA: a 1985 inception cohort study. J Rheumatol 21:1438-1446, 1994
5. Capell HA, Murphy EA, Hunter JA: Rheumatoid arthritis: workload and outcome over 10 years. QJM 79:461-476, 1994
6. Førre Ø, Norwegian Arthritis Study Group: Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Arthritis Rheum 37:1506-1512, 1994
7. Luukkainen R, Kajander A, Isomaki H: Effect of gold on progression of erosions in rheumatoid arthritis. Scand J Rheumatol 6:189-192, 1977
8. Eberhardt KB, Fex E: Functional impairment and disability in early rheumatoid arthritis - development over 5 years. J Rheumatol 22:1037-1042, 1995
9. Hess E, Luggen ME: Remodeling the pyramid - a concept whose time has not yet come (editorial). J Rheumatol 16:1175, 1989
10. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA: Nonsteroidal antiinflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 114: 257-263, 1991
11. Gabriel SE, Bombardier C: NSAID induced ulcers: an emerging epidemic? J Rheumatol 17:1-4, 1990
12. Fries JF, Williams CA, Bloch DA, Michel BA: NSAID-associated gastropathy: incidence and risk factor models. Am J Med 91:213-222, 1991
13. Fenner H: Nonsteroidal antiinflammatory drugs: benefit/risk evaluation in rheumatic diseases. J Rheumatol 19 (suppl 32):98-99, 1992
14. Fries JF, Williams CA, Ramey D, Bloch DA: The relative toxicity of disease-modifying antirheumatic drugs. Arthritis Rheum 36:297-306, 1993
15. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T: Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16:585-591, 1989
16. Guillemin F, Suurmeijer T, Krol B, Bombardier C, Briançon S, Doeglas D, Sanderman R, van den Heuvel W: Functional disability in early rheumatoid arthritis: description and risk factors. J Rheumatol 21:1051-1055, 1994
17. Pincus T, Callahan LF: What is the natural history of rheumatoid arthritis? Current controversies in clinical rheumatology. Rheum Dis Clin North Am 19:123, 1993
18. Wolfe F, Hawley DJ: Remission in rheumatoid arthritis. J Rheumatol 12:245-252, 1985
19. Pincus T: The paradox of effective therapies but poor long-term outcomes in rheumatoid arthritis. Semin Arthritis Rheum 21 (suppl 3):2, 1992
20. Felson DT, Anderson JJ, Meenan RF: Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. Arthritis Rheum 35:1117-1125, 1992
21. McCarty DJ, Carrera GF: Intractable rheumatoid arthritis: treatment with combined cyclophosphamide, azathioprine and hydroxychloroquine. JAMA 248:1718, 1982
22. Wilske KR, Healy LA: Remodeling the pyramid - a concept whose time has come. J Rheumatol 16:565-567, 1989
23. Wilke WS, Sherrer YR, Clough JD: Therapy for rheumatoid arthritis: combinations of disease modifying drugs and new paradigms. Semin Arthritis Rheum 21 (suppl 1):21, 1991
24. Fries JF: Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy. J Rheumatol 17 (suppl 22): 12-15, 1990
25. Epstein WV, Henke CJ, Yelin EH, Katz PP: Effect of parenterally administered gold therapy on the course of adult rheumatoid arthritis. Ann Intern Med 114:437-444, 1991
26. Wolfe F, Pincus T: Rheumatoid Arthritis. New York, Marcel Dekker, 1994
27. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Widmark R, Williams HJ, Wolfe F: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 36:729-740, 1993
28. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA: The mortality of rheumatoid arthritis. Arthritis Rheum 37:481-494, 1994
29. Sherrer YS, Bloch DA, Mitchell DM, Roth SH, Wolfe F, Fries JF: Disability in rheumatoid arthritis: comparison of prognostic factors across three populations. J Rheumatol 14:705-709, 1987
30. Ropes MW, Bennett GA, Cobb S, Jacox R, Jesar RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum 2:16-20, 1959
31. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
32. Fritz JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 23:137-145, 1980